• Return to Headlines

Relatively High EBITDA Growth Detected in Shares of Biotelemetry Inc in the Health Care Services Industry (BEAT, LHCG, CCRN, CHE, DPLO)

By Amy Schwartz

Below are the three companies in the Health Care Services industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biotelemetry Inc ranks highest with a EBITDA growth of 192.7%. Lhc Group Inc is next with a EBITDA growth of 171.5%. Cross Country He ranks third highest with a EBITDA growth of 137.1%.

Chemed Corp follows with a EBITDA growth of 89.1%, and Diplomat Pharmac rounds out the top five with a EBITDA growth of 72.3%.

SmarTrend is tracking the current trend status for Biotelemetry Inc and will alert subscribers who have BEAT in their portfolio or watchlist when shares have changed trend direction.

Keywords: highest ebitda growth biotelemetry inc lhc group inc cross country he chemed corp diplomat pharmac

Ticker(s): BEAT LHCG CCRN CHE DPLO